1.40
price down icon7.28%   -0.11
after-market Handel nachbörslich: 1.39 -0.01 -0.71%
loading

Finanzdaten der Black Diamond Therapeutics Inc-Aktie (BDTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
2.92%
20.25
20.86 24.01 20.03 21.56
Operating Income/Loss
2.92%
-20.25
-20.86 -24.01 -20.03 -21.56
Nonoperating Income/Loss
39.67%
2.021
1.447 1.005 0.88 0.686
Income/Loss From Continuing Operations Before Tax
6.10%
-18.23
-19.41 -23.01 -19.15 -20.88
Income/Loss From Continuing Operations After Tax
6.10%
-18.23
-19.41 -23.01 -19.15 -20.88
Net Income/Loss
6.10%
-18.23
-19.41 -23.01 -19.15 -20.88
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,902%
51.81
2.5873 50.94 36.52 36.48
Diluted Average Shares
1,902%
51.81
2.5873 50.94 36.52 36.48
Basic Earnings Per Share
2.94%
-0.35
-0.34 -0.45 -0.52 -0.57
Diluted Earnings Per Share
2.94%
-0.35
-0.34 -0.45 -0.52 -0.57
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):